Product Program year 2024 Source: CMS Open Payments

TandemLife

Device Cardiology/Vascular Diseases

PDI 00814112020470

Open in the dashboard

General payments

$13,559

221 payments

Research payments

$0

0 payments

Through program year 2024, $13,559 in general payments and $0 in research payments were reported against TandemLife (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $431 11
2023 General $10,213 161
2022 General $2,915 49

Breakdown

Who paid General payments · program years 2022–2024
  1. LivaNova USA, Inc. $13,559 221 payments
Top recipients General payments · program year 2024
  1. Yasin Khan Pulmonary Disease · New Orleans, LA $72 17% · 1 payment
  2. Michael Crain Pulmonary Disease · Birmingham, AL $39 9% · 1 payment
  3. Ronald Roan Anesthesiology · Talladega, AL $39 9% · 1 payment
  4. Jordan Ames Nurse Practitioner, Acute Care · Birmingham, AL $39 9% · 1 payment
  5. Megan Early Nurse Practitioner, Acute Care · Birmingham, AL $39 9% · 1 payment

The top 5 of 11 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Physician Assistant $117 27% · 3 practitioners
  2. Pulmonary Disease Internal Medicine $111 26% · 2 practitioners
  3. Nurse Practitioner, Acute Care Nurse Practitioner $78 18% · 2 practitioners
  4. Interventional Cardiology Internal Medicine $48 11% · 2 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $39 9% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Alabama $272 63% · 7 recipients
  2. Louisiana $72 17% · 1 recipient
  3. Pennsylvania $48 11% · 2 recipients
  4. Georgia $39 9% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

221 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record